Validation of a new breathing simulator generating and measuring inhaled aerosol with adult breathing patterns

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 13, Issue 2, 2000, Pages 139-146

  Nikander, Kurt ^a,b   Denyer, J ^c   Everard, M ^d   Smaldone, G G ^e  

^a ASTRAZENECA R AND D   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Medic Aid Limited   (United Kingdom)

^d SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

^e STONY BROOK UNIVERSITY   (United States)

Author keywords

Breathing simulator; Budesonide suspension for nebulization; Inhaled mass; Nebulizer in vitro in vivo validation

Indexed keywords

BUDESONIDE;

ADULT; AEROSOL; ARTICLE; BREATHING PATTERN; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; HUMAN; HUMAN EXPERIMENT; NEBULIZATION; NEBULIZER; NORMAL HUMAN; SIMULATION;

EID: 0033918289     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/089426800418668     Document Type: Article

References (14)

1. Smaldone, G.C. 1991. Drug delivery via aerosol systems: Concept of "Aerosol Inhaled." J. Aerosol Med. 4:229-235.
2. Nikander, K., M. Turpeinen, and P. Wollmer. 1999. The conventional ultrasonic nebulizer proved inefficient in nebulizing a suspension. J. Aerosol Med. 12:47-53.
3. Smaldone, G.C. 1994. Drug delivery by nebulisation: "reality testing." J. Aerosol Med. 7:213-216.
4. Everard, M.L., A.R. Clark, and A.D. Milner. 1992. Drug delivery from holding chambers with attached facemask. Arch Dis Child. 67:586-591.
5. Nikander, K. 1994. Drug delivery systems. J. Aerosol Med. 7(suppl. 1):S19-S24.
6. Burnell, P.K.P., A. Malton, K. Reavill, and M.H.E. Ball. 1998. Design, validation and initial testing of the Electronic Lung™ device. J. Aerosol Sci. 29:1011-1025.
7. Knoch, M., and E. Wunderlich. 1995. Effect of age related breathing parameters on the performance of a new nebulizer system: An in-vitro study. J. Aerosol Med. 8:285-288.
8. Mitchell, J.P., and M.W. Nagel. 1997. In vitro performance testing of three small volume-holding chambers under conditions that correspond with use by infants and small children. J. Aerosol Med. 10:341-349.
9. Smaldone, G.C., M. Cruz-Rivera, and K. Nikander. 1998. In vitro determination of inhaled mass and particle distribution for budesonide nebulizing suspension. J. Aerosol Med. 11:113-125.
10. Nikander, K., J. Denyer, and G.C. Smaldone. 1999. Effects of equipment deadspace and pediatric breathing patterns on inhaled mass of nebulized budesonide. J. Aerosol Med. 12:67-73.
11. O'Callaghan, C., and P.W. Barry. 1997. The science of nebulised drug delivery. Thorax. 52(suppl 2):S31-S44.
12. PrEN13554-1 Respiratory therapy equipment. Part 1 - Nebulizing System and their Components. BSI, Chiswick, London, W4 4AL.
13. Nikander, K., and H. Bisgaard. 1999. The impact of constant and breath-synchronized nebulization on the inhaled mass of nebulized budesonide in infants and children. Pediatr Pulmonol. 28:187-193.
14. Coates, A.L., C.F. MacNeish, L.C. Lands, D. Meisner, S. Kelemen, and E.B. Vadas. 1998. A comparison of the availability of tobramycin for inhalation from vented vs unvented nebulizers. Chest 113:951-956.